These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2933839)

  • 1. [Quantitative and functional characteristics of T-suppressors in patients with rheumatoid arthritis].
    Shirinskiĭ VS; Lozovoĭ VP
    Ter Arkh; 1985; 57(8):145-8. PubMed ID: 2933839
    [No Abstract]   [Full Text] [Related]  

  • 2. [T cell functions in rheumatic diseases].
    Sakane T; Takada S
    Ryumachi; 1982 Aug; 22(4):329-38. PubMed ID: 6217560
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppressor T cell activity in rheumatoid arthritis and systemic lupus erythematosus.
    Sakane T; Taniguchi Y; Honda M; Kotani H
    Ryumachi; 1981; 21 Suppl():115-22. PubMed ID: 6211784
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of suppressor T cell function in patients with rheumatoid arthritis: defects in production of and responsiveness to concanavalin A-induced suppressor T cells.
    Sakane T; Takada S; Murakawa Y; Kotani H; Honda M; Ueda Y
    J Immunol; 1982 Nov; 129(5):1972-7. PubMed ID: 6214584
    [No Abstract]   [Full Text] [Related]  

  • 5. Origin of defective T lymphocyte-suppressor activating factor interaction in patients with rheumatoid arthritis.
    Keystone EC; Budz-Tymkewycz S; Toews M; Lau C
    Clin Exp Immunol; 1987 Jul; 69(1):48-56. PubMed ID: 2958193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonspecific suppressor cells in rheumatoid arthritis. Con A and PHA induced suppressor cell activity.
    Dunne JV; Sengar DP; Pearson D; McKendry RJ; Gardell D
    J Clin Lab Immunol; 1982 Nov; 9(2):99-104. PubMed ID: 6218307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Suppressor T-lymphocytes in continuously progressive juvenile schizophrenia].
    Maznina TP; Mikheeva TV; Lavrov VF; Abramova LI; Koliaskina GI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):1065-9. PubMed ID: 6236659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The suppressor cell activity in rheumatoid arthritis].
    Vogelsang H; Hein G; Jäger L
    Z Rheumatol; 1980; 39(5-6):141-4. PubMed ID: 6447962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Etiopathogenetic aspects of psoriatic arthritis with special reference to immunologic factors].
    Hein G; Henzgen M; Vogelsang H; Knopf B
    Z Gesamte Inn Med; 1984 Nov; 39(21):537-9. PubMed ID: 6240837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Con A induceable suppressor cell activity in rheumatoid arthritis].
    Vogelsang H; Hein G; Jäger L
    Z Rheumatol; 1982; 41(3):100-4. PubMed ID: 6214105
    [No Abstract]   [Full Text] [Related]  

  • 11. Enumeration of T cell subsets and functional suppressor cell assays in patients with rheumatoid arthritis and HLA-B27-associated arthritis.
    Lemm G; Warnatz H
    Z Rheumatol; 1984; 43(3):106-12. PubMed ID: 6236640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of A-cells on the activity of nonspecific T-suppressors in rheumatoid arthritis patients].
    Shirinskiĭ VS
    Revmatologiia (Mosk); 1985; (3):62-5. PubMed ID: 2932787
    [No Abstract]   [Full Text] [Related]  

  • 13. [T suppressor lymphocyte study in rheumatic diseases].
    Shirinskiĭ VS; Loĭko TP; Konenkov VI; Lozovoĭ VP
    Ter Arkh; 1982; 54(12):113-7. PubMed ID: 6218643
    [No Abstract]   [Full Text] [Related]  

  • 14. [Disorders of cell-mediated immunity in rheumatoid arthritis].
    Sheĭtanov I
    Vutr Boles; 1984; 23(4):10-3. PubMed ID: 6239453
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of therapy, serology, stage and activity of rheumatoid arthritis on lymphocyte stimulation in whole blood].
    Fritze U; Fritze D; Bicker U; Ewald RW; Friedberg KD
    Z Rheumatol; 1983; 42(3):101-3. PubMed ID: 6880408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of chrysotherapy on T-lymphocyte subpopulations in rheumatoid arthritis.
    Pfreundschuh M; Parino G; Gram N; Bröker A; Gause A; Hunstein W
    Z Rheumatol; 1983; 42(6):328-31. PubMed ID: 6229937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated T cells complicate the identification of regulatory T cells in rheumatoid arthritis.
    Aerts NE; Dombrecht EJ; Ebo DG; Bridts CH; Stevens WJ; De Clerck LS
    Cell Immunol; 2008 Feb; 251(2):109-15. PubMed ID: 18538752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies.
    Berrih S; Gaud C; Bach MA; Le Brigand H; Binet JP; Bach JF
    Clin Exp Immunol; 1981 Jul; 45(1):1-8. PubMed ID: 6458432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The study of a lymphokine, polymorphonuclear leukocyte chemotactic factor from lymphocytes in rheumatoid arthritis.
    Pazdur J; Winney C; Baum J
    J Clin Lab Immunol; 1982 Apr; 7(3):179-85. PubMed ID: 7047743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective loss of suppressor T cells in rheumatoid arthritis patients: analysis of peripheral blood lymphocytes by 2-dimensional flow cytometry.
    Goto M; Miyamoto T; Nishioka K; Okumura K
    J Rheumatol; 1986 Oct; 13(5):853-7. PubMed ID: 2950232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.